Literature DB >> 9197395

Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens.

R El Ridi1, S Ismail, T Gaafar, M El Demellawy.   

Abstract

Schoolchildren (7-8 years old) infected with Schistosoma haematobium were tested for lymphocyte proliferative responses, in vitro granuloma formation (IVGF), and cytokine release in T-cell Western assays and for serum antibody reactivity by enzyme-linked immunosorbent assay (ELISA) and immunoblotting against S. haematobium soluble adult-worm (SAWA) and egg (SEA) antigens. The lymphoproliferative response rate of individual subjects against 10 SAWA and 15 SEA electroseparated bands ranged from 0 to 33% and from 11 to 66%, respectively. The SAWA bands essentially failed to elicit significant IVGF, in contrast to the SEA bands, all of which were capable of inducing IVGF from peripheral blood mononuclear cells (PBMC) of 30-80% of individual donors. The exclusive ability of SEA bands to induce IVGF could not be attributed to selective release of interleukin 2 (IL-2), IL-4, or interferon-gamma, as SEA and SAWA bands were capable of eliciting release of a similar array of cytokines in supernatants of 4-day PBMC cultures. The antibody response to SEA was stronger than that to SAWA, yet the proportion of SAWA bands binding humoral antibodies of individual donors was significantly larger than that observed for SEA. The study thus suggests that humans with early-stage S. haematobium infection respond poorly to SAWA but mount strong cellular immune responses to SEA that result in granuloma and antibody formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197395     DOI: 10.1007/s004360050282

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

1.  Comparative analysis of the diagnostic performance of adult, cercarial and egg antigens assessed by ELISA, in the diagnosis of chronic human Schistosoma mansoni infection.

Authors:  Rania Mohammad Sarhan; Heba AbdelKader Aminou; Ghada Abdel Rahman Saad; Ossama Ashraf Ahmed
Journal:  Parasitol Res       Date:  2014-07-16       Impact factor: 2.289

2.  Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy.

Authors:  R El Ridi; C B Shoemaker; F Farouk; N H El Sherif; A Afifi
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Association of in utero sensitization to Schistosoma haematobium with enhanced cord blood IgE and increased frequencies of CD5- B cells in African newborns.

Authors:  Larsen S Seydel; Annika Petelski; Govert J van Dam; Desiree van der Kleij; Yvonne C M Kruize-Hoeksma; Adrian J F Luty; Maria Yazdanbakhsh; Peter G Kremsner
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

4.  A novel mouse model of Schistosoma haematobium egg-induced immunopathology.

Authors:  Chi-Ling Fu; Justin I Odegaard; De'Broski R Herbert; Michael H Hsieh
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

Review 5.  Acquired immune heterogeneity and its sources in human helminth infection.

Authors:  C D Bourke; R M Maizels; F Mutapi
Journal:  Parasitology       Date:  2010-10-15       Impact factor: 3.234

6.  Soluble egg antigen of Schistosoma Haematobium induces HCV replication in PBMC from patients with chronic HCV infection.

Authors:  Mostafa K El-Awady; Samar S Youssef; Moataza H Omran; Ashraf A Tabll; Wael T El Garf; Ahmed M Salem
Journal:  BMC Infect Dis       Date:  2006-06-06       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.